Over the past decade, non-coding RNA-based therapeutics have proven as a great potential
for the development of targeted therapies for cancer and other diseases. The discovery of …

Functional nucleic acid (NA)-based drugs have a broad range of applications since they
allow the alteration and control of gene/protein expression patterns in cells. In principle …

The combination of photothermal therapy (PTT) and gene therapy (GT) shows great
potential to achieve synergistic anti-tumor activity. However, the lack of a controlled release …

Exosome is a subgroup of extracellular vesicles, which has been serving as an efficient
therapeutic tool for various diseases. Engineered exosomes are the sort of exosomes …

Breast cancer is the most prevalent cancer among women worldwide. However, increased
survival is due to the dramatic advances in the screening methods, early diagnosis, and …

Background RNA interference (RNAi), a newly developed method in which RNA molecules
inhibit gene expression, has recently received considerable research attention. In the …

Short interfering RNAs (siRNAs), as small non-coding RNA fragments, are one of the widely
studied RNAi inducers for gene modulations. The reasonably designed siRNA probes …

Carbon nanotubes (CNTs), a versatile nanocarrier for doxorubicin (DOX) delivery had
attracted significant attention in drug delivery of pharmaceuticals. Several properties such as …

Carbon nanotubes (CNTs) have received increasing attention in biomedical fields because
of their unique structures and properties, including high aspect ratios, large surface areas …

Breast carcinomas repeat their number and grow exponentially making it extremely frequent
malignancy among women. Approximately, 70–80% of early diagnosed or non-metastatic …